ADVERTISEMENT

If you are seeing this message, you may be experiencing temporary network problems. Please wait a few minutes and refresh the page. If the problem persists, you may wish to report it to your local Network Manager.

It is also possible that your web browser is not configured or not able to display style sheets. In this case, although the visual presentation will be degraded, the site should continue to be functional. We recommend using the latest version of Microsoft or Mozilla web browser to help minimise these problems.

Wiley InterScience

Australasian Journal of Dermatology

Australasian Journal of Dermatology

Volume 19 Issue 2, Pages 72 - 73

Published Online: 28 Jun 2007

Journal compilation © 2010 The Australasian College of Dermatologists



< Previous Abstract  |  Next Abstract >

Save Article to My Profile      Download Citation      Request Permissions

Abstract |  Full Text: PDF (Size: 2075K)  | Related Articles | Citation Tracking

A DOUBLE-BLIND CONTROLLED EVALUATION OF DIPROSONE CREAM 0.05% IN COMPARISON WITH SYNALAR CREAM 0.01% IN THE TREATMENT OF PSORIASIS AND OTHER STEROID RESPONSIVE DERMATOSES
M. B. Lewis 1
  1 Sydney
Correspondence to  Address for reprints: Dr. M. B. Lewis, Suite 1202, Bondi Junction Office Plaza, 500 Oxford Street, Bondi Junction, N.S.W. 2022.
Copyright 1978 Blackwell Science Asia Pvt. Ltd.

ABSTRACT

Abstract

A three-week double-blind randomized study was carried out to compare the effect of Diprosone cream 0.05% with Synalar cream 0.01%. Forty patients suffering from psoriasis and other steroid responsive dermatoses were included in the study. The disease status was carefully monitored throughout the period of the study and parameters were measured to determine the efficacy, onset of action, tolerance and cosmetic acceptability of the two preparations under study. It was concluded that both preparations were efficacious in the treatment of psoriasis and other steroid responsive dermatoses, and that there was no statistically significant difference between the two preparations in the parameters evaluated, other than in the treatment of psoriasis when the parameter of scaling was measured.

Side effects were recorded in two patients receiving Synalar, and one receiving Diprosone, during this study.


DIGITAL OBJECT IDENTIFIER (DOI)
10.1111/j.1440-0960.1978.tb00195.x About DOI

Related Articles

  • Find other articles like this in Wiley InterScience
  • Find articles in Wiley InterScience written by any of the authors

Wiley InterScience is a member of CrossRef.

Cross Ref Member


Latest News & Information
Free access